Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new global head of corporate affairs, as the obesity drugmaker faces growing pressure from U.S. President Donald Trump on ...
President Trump said he would lower the prices of popular weight-loss drugs, pressuring shares of drugmakers Novo Nordisk and ...
Get the latest healthcare stock updates, key pharma deals, and major legal developments impacting the S&P 500.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback